Comparison of interferon-gamma production between TB1 and TB2 tubes of QuantiFERON-TB Gold Plus: a meta-analysis
- PMID: 37221870
- DOI: 10.1515/cclm-2023-0293
Comparison of interferon-gamma production between TB1 and TB2 tubes of QuantiFERON-TB Gold Plus: a meta-analysis
Abstract
Objectives: CD8 T-cells play an important role in interferon-gamma (IFN-γ) production as a host defense against tuberculosis (TB) infection. Therefore, QuantiFERON-TB Gold Plus (QFT-Plus) was developed by adding a TB2 tube beside the TB1 tube. This study aimed to compare and analyze the difference in IFN-γ production between the two tubes in general and specific populations.
Content: PubMed, Web of Science, and EBSCO were searched for studies reporting IFN-γ production levels in the TB1 and TB2 tubes. Statistical analysis was performed using RevMan 5.3.
Summary: A total of 17 studies met the inclusion criteria. The IFN-γ production in the TB2 tube was statistically higher than that in the TB1 tube (mean difference (MD)=0.02, 95 % confidence interval (95 % CI): 0.01-0.03). Further subgroup analysis in specific populations revealed that the MD of IFN-γ production between the TB2 and TB1 tubes was significantly higher in active TB subjects than in latent TB infection (LTBI) subjects (MD=1.13, 95 % CI: 0.49-1.77, and MD=0.30, 95 % CI: 0.00-0.60, respectively). A similar finding was found in immune-mediated inflammatory disease subjects, but not statistically significant. Interestingly, IFN-γ production capacity was lower in active TB subjects than in LTBI subjects in each of the TB1 and TB2 tubes.
Outlook: This study is the first to systematically compare IFN-γ production between the TB1 and TB2 tubes. The IFN-γ production was higher in the TB2 tube than in the TB1 tube, representing the host's CD8 T-cell response magnitude to TB infection.
Keywords: CD8 T-cells; QuantiFERON-TB Gold Plus; TB1 tube; TB2 tube; interferon-gamma.
© 2023 Walter de Gruyter GmbH, Berlin/Boston.
Similar articles
-
Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study.Microbiol Spectr. 2021 Dec 22;9(3):e0097221. doi: 10.1128/Spectrum.00972-21. Epub 2021 Nov 10. Microbiol Spectr. 2021. PMID: 34756079 Free PMC article.
-
Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus.J Infect Chemother. 2020 Jun;26(6):570-574. doi: 10.1016/j.jiac.2020.01.011. Epub 2020 Feb 14. J Infect Chemother. 2020. PMID: 32067903
-
Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit.Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S25-S26. doi: 10.1016/j.ijmyco.2016.09.063. Epub 2016 Nov 11. Int J Mycobacteriol. 2016. PMID: 28043588
-
Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-γ release assays: A systematic review and meta-analysis.Adv Med Sci. 2019 Sep;64(2):437-443. doi: 10.1016/j.advms.2019.09.001. Epub 2019 Oct 3. Adv Med Sci. 2019. PMID: 31586819
-
QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis.J Infect. 2019 Nov;79(5):444-453. doi: 10.1016/j.jinf.2019.08.018. Epub 2019 Aug 29. J Infect. 2019. PMID: 31473271
Cited by
-
Interferon-Gamma Release Assay Testing for Latent Tuberculosis Infection: A Health Technology Assessment.Ont Health Technol Assess Ser. 2024 Dec 12;24(11):1-183. eCollection 2024. Ont Health Technol Assess Ser. 2024. PMID: 39911267 Free PMC article.
-
Predicting stringent QuantiFERON-TB Gold Plus conversions in contacts of tuberculosis patients.J Microbiol Immunol Infect. 2023 Oct;56(5):1073-1083. doi: 10.1016/j.jmii.2023.07.014. Epub 2023 Aug 4. J Microbiol Immunol Infect. 2023. PMID: 37580184 Free PMC article.
References
-
- Chakaya, J, Khan, M, Ntoumi, F, Aklillu, E, Fatima, R, Mwaba, P, et al.. Global tuberculosis report 2020 – reflections on the global TB burden, treatment and prevention efforts. Int J Infect Dis 2021;113:S7–12. https://doi.org/10.1016/j.ijid.2021.02.107 . - DOI
-
- Kim, SH, Jo, KW, Shim, TS. QuantiFERON-TB Gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infection. Korean J Int Med 2019;35:383. https://doi.org/10.3904/kjim.2019.002 . - DOI
-
- Domingo-Gonzalez, R, Prince, O, Cooper, A, Khader, S. Cytokines and chemokines in mycobacterium tuberculosis infection. Microbiol Spectr 2016;4:1–5. https://doi.org/10.1128/microbiolspec.TBTB2-0018-2016 . - DOI
-
- Goletti, D, Delogu, G, Matteelli, A, Migliori, GB. The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection. Int J Infect Dis 2022;7:39. https://doi.org/10.1016/j.ijid.2022.02.047 . - DOI
-
- Sharma, SK, Vashishtha, R, Chauhan, LS, Sreenivas, V, Seth, D. Comparison of TST and IGRA in diagnosis of latent tuberculosis infection in a high TB-burden setting. PLoS One 2017;12:e0169539. https://doi.org/10.1371/journal.pone.0169539 . - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous